Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
NAT1–ENO1–Lactate Signaling in Colorectal Cancer
2026-09-30
A 2026 MedComm study defines NAT1 as a metabolic–immune regulator that restrains ENO1 activity, lactate production, and TRAF6-dependent PD-L1 stabilization in colorectal cancer. Its integrated database, multi-omics, patient, cellular, and mouse-model evidence provides a mechanistic framework for understanding how glycolytic metabolism may influence immune-checkpoint response, while also clarifying the limits of translating LDHA-focused experiments into colorectal cancer immunotherapy research.
Dibutyryl-cAMP, sodium salt for Signaling Studies
2026-09-30
Dibutyryl-cAMP, sodium salt provides a practical way to elevate intracellular cAMP while testing PKA-linked responses in cells and brain-relevant models. This workflow-focused guide covers dose design, organotypic slice experiments, neuronal applications, inflammation studies, and troubleshooting for reproducible pathway interpretation.
Annexin V-HF647/PI Apoptosis Kit in ESCC
2026-09-29
The Annexin V-HF647/PI Apoptosis Kit enables a practical, single-cell view of apoptosis during HOXC9 and AKT/mTOR studies in esophageal squamous cell carcinoma. This guide explains assay biology, experimental design, controls, interpretation, and the limits of linking Annexin V/PI results to mitochondrial mechanisms.
Pemetrexed Workflows for Folate-Pathway Studies
2026-09-29
Use Pemetrexed as more than a cytotoxic readout: it is a practical perturbation tool for mapping folate metabolism, nucleotide stress, and DNA-repair vulnerabilities. This workflow-focused guide connects dose-response design with malignant mesothelioma models and translational assay interpretation.
MLN2238: From β5 Inhibition to Translational Insight
2026-09-28
MLN2238 offers a mechanistically defined route into proteasome stress biology, linking β5-centered proteolytic control with apoptosis, resistance research, and ROS–JNK–CREB adaptation. This article translates those insights into a practical framework for oncology and proteostasis researchers.
Epilepsy-Associated Cardiac Biomarkers in Baboons
2026-09-28
A retrospective study in a captive baboon pedigree found prolonged QT and Fridericia-corrected QT intervals in epileptic animals, alongside a non-significant tendency toward lower heart rate variability. The findings support further study of cardiac measures in epilepsy, but do not establish inherited risk or predict sudden unexpected death in epilepsy.
Escitalopram in Serotonergic Assay Design
2026-09-27
Use Escitalopram as a potency-characterized probe to measure serotonin-transporter function, then connect those mechanistic readouts to the limits of clinical evidence in anxious depression. This workflow emphasizes vehicle control, concentration-response design, and careful interpretation—not assumptions that a cell assay predicts clinical benefit.
IR-1061 for Deep-Tissue NIR Imaging Workflows
2026-09-26
IR-1061 is a near infrared fluorescent dye for OTN-NIR research, but its performance depends on how it is formulated—not simply on the amount of dye added. This workflow-focused guide translates polymer-encapsulation findings into practical loading, control, and troubleshooting choices for deep-tissue imaging studies.
Pemetrexed in Mesothelioma: Reading DNA Repair Context
2026-09-25
Pemetrexed is more than a cytotoxic benchmark: its effects can be interpreted alongside tumor DNA-repair state. This article explains how to separate antifolate response from homologous-recombination vulnerability when designing malignant mesothelioma research.
Chloroquine: From Lysosomal Mechanism to Translation
2026-09-25
Chloroquine is a powerful research probe—but its lysosomal effects, broad immune activity, and uneven translation across models demand careful experimental interpretation.
Tetrahydromagnolol in CB2 Signaling Workflows
2026-09-24
Use Tetrahydromagnolol to probe CB2-linked signaling and test carefully framed hypotheses about inflammation or cell motility. Its reported CB2 potency and GPR55 antagonism support dose-aware workflows—but do not establish a role in the TBXA2R–ERM pathway.
ABT-263 (Navitoclax): Mechanism and Research Use
2026-09-24
ABT-263 (Navitoclax) inhibits anti-apoptotic Bcl-2 family proteins and is used to investigate mitochondrial apoptosis in cancer models. Its value in an apoptosis assay depends on the model’s apoptotic priming and survival-protein profile, so results should not be inferred from target expression alone.
ARCA Cy5 EGFP mRNA (5-moUTP): Assay Guide
2026-09-23
Track labeled mRNA and its translated EGFP product in the same experiment to distinguish delivery from expression. This practical guide shows how to use the reporter to optimize cell-based delivery assays—and where conclusions should stop before moving to disease models.
Laminin (925-933): A Mechanism-First Assay Guide
2026-09-23
Laminin (925-933) is a defined Laminin B1 chain peptide for dissecting receptor-dependent adhesion and chemotaxis. This guide connects its ECM biology with lessons from tau research to improve assay controls, interpretation, and translational relevance.
Disulfiram Workflows for Proteasome and Pyroptosis
2026-09-22
Disulfiram supports two complementary research workflows: copper-associated proteasome inhibition in cancer models and covalent modulation of GSDMD-linked pyroptosis. This guide translates those mechanisms into practical assay design, dosing, controls, and troubleshooting strategies.
8141 records 6/543 page Previous Next First page 上5页 678910 下5页 Last page